Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

RegenMedTX

RegenMedTX
2014 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
Description

Developer of cell therapies for chronic kidney disease. The company develops cell therapy products that are programmed in the body to restore damaged kidney tissues by engrafting into, repairing or replacing damaged tissues or organ.

Ownership Status
Acquired/Merged
Financing Status
Formerly Angel backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 3929 Westpoint Boulevard
  • Suite G
  • Winston-Salem, NC 27103
  • United States

+1 (336) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore RegenMedTX’s full profile, request a free trial.

RegenMedTX Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Mar-2016 00.000 Completed Startup
1. Angel (individual) 05-Aug-2015 00.000 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

RegenMedTX Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 06-Mar-2015 000000000000000000 000.00 Biotechnology
To view this company’s complete investment and acquisition history, request access »

RegenMedTX Executive Team (2)

Name Title Board
Seat
Contact
Info
Timothy Bertram Ph.D Chief Executive Officer, Board Member and Managing Director
Deepak Jain Ph.D Chief Operating Officer

RegenMedTX Board Members (3)

Name Representing Role Since Contact
Info
Kim Westmoreland Self Board Member 000 0000
Timothy Bertram Ph.D RegenMedTX Chief Executive Officer, Board Member and Managing Director 000 0000
William Hawkins III Self Chairman 000 0000